GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.510
+0.070 (4.86%)
At close: Apr 4, 2025, 4:00 PM
1.600
+0.090 (5.96%)
After-hours: Apr 4, 2025, 4:26 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $793.29 thousand as of April 4, 2025. Its market cap has increased by 62.66% in one year.
Market Cap
793.29K
Enterprise Value
-4.15M
1-Year Change
62.66%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.38M to $793.29K, a decrease of -96.87%. That is a compound annual growth rate of -83.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2025 | 756.52K | -89.78% |
| Dec 31, 2024 | 7.40M | 325.43% |
| Dec 29, 2023 | 1.74M | -93.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 708.59B |
| UnitedHealth Group | 494.35B |
| Johnson & Johnson | 385.14B |
| AbbVie | 356.70B |
| Novo Nordisk | 300.62B |
| AstraZeneca | 231.80B |
| Abbott Laboratories | 228.29B |
| Merck & Co. | 218.22B |